Oesophageal Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with lung cancer or esophageal cancer and have agreed to receive a type of immunotherapy that targets PD-1 or PD-L1
• People aged between 18 and 80 years old
• People who are fully active or have only minor restrictions in physical activity (this is measured using a standard scale called ECOG PS, with a score of 0 or 1)
• People whose organs and bone marrow are functioning well enough to participate
• People whose doctors expect them to live for at least 12 weeks
• People who are willing and able to sign a written consent form

Who may not be able to join:

• People who have blood-borne infectious diseases, such as HIV, hepatitis B, or hepatitis C
• People whose cancer has caused an urgent medical emergency that needs immediate treatment
• People with poor vein or blood vessel condition (confirm with trial site)
• People whose blood does not clot normally, or who are currently taking blood-thinning or clot-dissolving medication
• People who have a psychiatric disorder or severe mental illness
• People who have difficulty communicating or who would be unable to attend follow-up appointments over time
• People who the trial team determines are not suitable for the study for other reasons (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.